Herbal medicine use in pregnancy: results of a multinational study by Kennedy, Deborah A et al.
RESEARCH ARTICLE Open Access
Herbal medicine use in pregnancy: results of a
multinational study
Deborah A Kennedy1*†, Angela Lupattelli2†, Gideon Koren1† and Hedvig Nordeng2,3†
Abstract
Background: The use of complementary and alternative medicines (CAM) is growing in the general population.
Herbal medicines are used in all countries of the world and are included in the top CAM therapies used.
Methods: A multinational study on how women treat disease and pregnancy-related health ailments was
conducted between October 2011 and February 2012 in Europe, North and South America and Australia. In this
study, the primary aim was to determine the prevalence of herbal medicine use in pregnancy and factors related to
such use across participating countries and regions. The secondary aim was to investigate who recommended the
use of herbal medication in pregnancy.
Results: There were 9,459 women from 23 countries participating in the study. Of these, 28.9% reported the use of
herbal medicines in pregnancy. Most herbal medicines were used for pregnancy-related health ailments such as
cold and nausea. Ginger, cranberry, valerian and raspberry were the most commonly used herbs in pregnancy. The
highest reported rate of herbal use medicines was in Russia (69%). Women from Eastern Europe (51.8%) and
Australia (43.8%) were twice as likely to use an herbal medicine versus other regions. Women using herbal
medicines were characteristically having their first child, non-smokers, using folic acid and consuming some alcohol
in pregnancy. Also, women who were currently students and women with an education other than a high school
degree were more likely to use herbal medicines than other women. Although 1 out of 5 women stated that a
physician had recommended the herbal use, most women used herbal medicine in pregnancy on their own
initiative.
Conclusions: In this multinational study herbal medicine use in pregnancy was high although there were distinct
differences in the herbs and users of herbal medicines across regions. Most commonly the women self-medicated
with herbal medicine to treat pregnancy-related health ailments. More knowledge regarding the efficacy and safety
of herbal medicines in pregnancy is warranted.
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Background
In the past two decades the use of complementary and al-
ternative medicine (CAM) has grown considerably
worldwide [1]. In the European Union, the prevalence of
herbal medicine use ranges from 5.9% to 48.3%, whereas
herbal medicine use in the USA and Canada is estimated
to be 17.9% and 12%, respectively [2-4]. Herbal medicines
are used in all countries of the world and are included in
the top CAM therapies used [1,4-6]. Surveys on the use
of herbal medicines in pregnancy have reported a wide
range of herbal medicine use. In the Western world,
prevalence estimates of herbal medicine use in pregnancy
varies considerably across countries, ranging from 52-
58% in Australia and the United Kingdom [7,8], to 40-
48% in Norway and Italy [9,10] and 6-9% in Canada and
the US [11,12]. It is difficult to ascertain whether the dif-
ferences in prevalence are caused by differences in study
design, methodology and exposure ascertainment across
studies or whether they represent true differences
in herbal medicine use. Uniform data collection simul-
taneously in different countries may overcome such
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drawbacks, allow for inter-country comparability and
shed light on differences in the use of herbal medicines
in various countries.
The top herbals medicines used in pregnancy have
been found to include ginger, cranberry, raspberry, ech-
inacea and chamomile, with geographical variations [13].
Often herbal medicines have been used as a comple-
mentary therapy, concurrent with pharmaceutical drugs
rather than strictly as an alternative [9].
In general, studies have found that herbal medicine
users are women over the age of 35, with a higher edu-
cation and prior pregnancy [14,15]. A recent review
summarized the reported motivations for a woman’s use
of CAM therapies in pregnancy which include: the belief
that these therapies provided safe alternatives to phar-
maceutical drugs, an appreciation of a holistic potential
afforded by these therapies and a desire to have control
and satisfaction in their pregnancy experience [13].
Most of the previous surveys conducted in the use of
herbal medicines in pregnancy have been performed in a
specific antenatal clinic or a limited geographical area
and have rarely explored the use of herbal medicines for
chronic disease conditions. We sought to leverage the
technological advances afforded by the internet to reach
pregnant women in many countries simultaneously and
explore the use of herbal medicines for both pregnancy
related ailments and chronic conditions.
The objective of this study was to characterize the
prevalence of herbal medicine use in pregnancy and the
characteristics of herbal medicine users in pregnancy
from a multinational perspective. Specifically, we sought
to investigate the reasons for herbal medicine use and the
herbal medicines used for both chronic and pregnancy-
related health ailments. The secondary objective was to
examine who recommended the use of herbal medicine to
the pregnant women.
Methods
This was a multinational, cross-sectional, internet-based
study. Invitations to participate in the project were exten-
ded to countries of the European Network of Teratology
Information Services (ENTIS), Mothersafe in Australia, the
Organization of Teratology Information Specialists (OTIS)
in North and South America and other European institu-
tions conducting public health research. The following
countries agreed to participate: Australia, Austria, Canada,
Croatia, Finland, France, Iceland, Italy, Norway,
Poland, Russia, Serbia, Slovenia, Sweden, Switzerland,
The Netherlands, United Kingdom, and USA. Data origin-
ating from some South and Central America countries
(Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador,
Paraguay, Peru, Uruguay and Venezuela) was also collected.
To minimize recall bias, women were eligible to par-
ticipate if they were pregnant or had at least one child
under one year of age. Study participants were catego-
rized by reported country of residence at the time of the
completion of the questionnaire. Country of residence
was combined into six regions: Western Europe, Northern
Europe, Eastern Europe, North America, South America
and Australia.
An online self-completed questionnaire was developed
and was open to the public via utilization of banners
(invitations to participate in the study) on national
websites and/or social networks commonly visited and
consulted by pregnant women and/or new mothers. The
websites also included Teratology Information Services
(TISs), Organization for Teratology Information Services
(OTIS) webpages, social networking sites, pregnancy
forums and e-mail newsletters. Detailed information on
recruitment locations and internet penetration rates are
summarized in Additional file 1. The recruitment phase
was between October 1 2011 and February 29 2012. The
survey questionnaire was administered by Questback
(http://www.questback.com). In each participating coun-
try, the questionnaire was accessible online for a period
of two months.
The questionnaire was first developed in Norwegian
and English. Translation into the relevant languages was
performed; back-translation to English was done for spe-
cific parts of the questionnaire (i.e. psychometric scales)
by two independent native speakers and/or translators.
The questionnaire was translated into the following
languages; Croatian, Dutch, Finnish, French, German,
Icelandic, Italian, Norwegian, Polish, Russian, Serbian,
Slovenian, Spanish and Swedish. A pilot phase of the
study was carried out in September 2011 in Norway,
Sweden, Finland and Italy (n = 47). The analysis of pilot
data did not identify any major issues to the question-
naire. Collected data were scrutinized for the presence
of potential duplicates (based on reported country of
residency, socio-demographic characteristics, date and
exact time of questionnaire completion) but none were
identified. As a means of assessing external validity,
socio-demographic and lifestyle characteristics of the
questionnaire respondents was compared to those of
the general birthing population in the corresponding
country. National Statistics Bureau reports or national
studies were used as the source for these comparisons
(see Additional file 2).
Consent was obtained as follows: upon clicking on the
link to the survey, each woman was presented with a
description of the study and asked whether she was will-
ing to participate. Informed consent was given by ticking
a Yes response. Study approval was obtained from the
Regional Ethic Committee, Region South-East in Norway
and relevant Ethics Boards in each specific country.
Permission to analyze the herbal medicine study data
was also obtained from the Research Ethic Board of the
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Hospital for Sick Children, Toronto, Canada. All data
were handled and stored anonymously.
The online questionnaire captured data on maternal
health, socio-demographic, and lifestyle characteristics
as well as use of herbal, and conventional medicines in
pregnancy. The question “Did you take any herbal
preparations during pregnancy (e.g. ginger, echinacea,
valerian, cranberries)? If yes, please provide the name of
all herbal preparations you have taken during preg-
nancy” was posed to all study participants. Women
could report as free text entry the names of all herbal
medicines used in pregnancy, along with the reason for
its use, the period of use during pregnancy and the
recommendation source(s). In addition, herbal medicine
use could be reported under the specific questions about
diseases and pregnancy-related health ailments. The
relevant sections of the questionnaire are detailed in
Additional file 3.
We defined herbal medicine according to the World
Health Organization’s definition of any medicinal prod-
uct based on herbs, herbal materials, herbal preparations
and finished herbal products, that contain as active
ingredients parts of plants, other plant materials, or
combinations thereof [16]. Medicinal products based on
animal components, vitamins, minerals or homeopathic
products were not considered as herbal medicines.
The responses to the herbal medicine text field were
coded according to a pre-determined classification list of
herbs by the national coordinator in each participating
country. The pre-determined classification list was
compiled by the study development team and included
the herb’s common name, latin name and a 7 character
specific code following the format of the World Health
Organization’s Anatomical Therapeutic Chemical (ATC)
code convention as a means to standardize the coding in
the questionnaire database. When a product name
representing a multi-herbal combination or combination
product was entered, an internet search on the product
name was performed and the botanical ingredient(s)
coded according to the pre-determined classification list.
When the woman reported using several herbal medi-
cines and several reasons for use consecutively, the order
of reporting was used to match the herbal medicine and
its use. The form of the herbal medicine was not spe-
cifically requested (tea, tablet, or tincture). Period of use
was defined as weeks 1 - 12 (first trimester), 13-24 weeks
(second trimester) and week 25 to delivery (third trimester)
and presented as selection options. Several recommenda-
tion sources could be checked off: my own choice, family/
friends, physician, midwife/nurse, pharmacist, herbal shop
staff, internet, magazine/media/etc or other.
Reasons for use were recorded and grouped into the
following categories: preparation for labor, health pro-
motion, nausea, anemia, cold/flu, urinary tract infections
(UTIs), pain conditions, constipation, heartburn, gastro-
intestinal disorders/flatulence, sedative/sleeping problems,
restless legs, water retention and prevention of premature
delivery.
Maternal characteristics included age, marital status,
educational level, mother tongue, employment status,
parity, pregnancy intention, and information on use of
assisted reproductive technology. Life-style characteris-
tics included folic acid use and smoking status before
and during pregnancy and alcohol consumption after
awareness of pregnancy. Both disease specific and ques-
tions regarding pregnancy-related health ailments and
how they were treated were included in the question-
naire. Participating women were first presented with a
list of questions related to acute/short-term illnesses
(e.g. nausea, UTIs) and chronic/long-term disorders
(e.g. asthma, depression) and asked whether they suf-
fered from these conditions during pregnancy. In cases
with an affirmative response, women were questioned
about medication use for each individual indication as
free-text entry fields. Conventional medications were
coded according to the World Health Organization’s ATC
classification system [17].
Descriptive statistics were used to calculate the preva-
lence (%) and associated standard error (SE) of herbal
medicine use in pregnancy, reasons for use and informa-
tion sources. If a point estimate had a SE greater than
50%, an “*” was used and the point estimate was not
reported. Univariate and multivariate logistic regression
analysis was used to identify significant factors associ-
ated with herbal medicine use among study participants.
The analyzed maternal characteristics included region of
residence, age, parity, marital status, employment status,
education level, use of folic acid prior to and/or during
pregnancy, alcohol use after awareness of pregnancy and
smoking during pregnancy. First the univariate logistic
regression model was fit for all explanatory variables.
From this, the multivariate model was built and adjusted
for relevant covariates. A p-value of <0.05 was consid-
ered statistically significant. The Hosmer and Lemeshow
test was used to assess goodness of fit of the final multi-
variate model [18]. The data are presented as adjusted
odds ratios (aOR) with 95% confidence intervals (CI).
All statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) version 20.0
(IBM® SPSS® Statistics, Armonk, USA).
Results
A total of 9,459 women responded to this internet
survey from six different regions and 23 countries. The
majority of study participants were women from
Western Europe (n = 3,201), followed by Northern
Europe (n = 2,820), Eastern Europe (n = 2,342), North
America (n = 533), South America (n = 346) and Australia
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n = 217). Figure 1 summarizes the participant flow chart
to achieve the final study population. The overall sample
reflected well the birthing populations in each participat-
ing country with respect age, parity and smoking habits
(see Additional file 2). However, our sample comprised a
greater number of women with high educational levels
versus the general birthing population in each country.
Women in Australia, USA, The Netherlands, Slovenia,
Croatia and Serbia were somewhat older than their
respective countries’ birthing populations; while, women
in Austria, Italy and Sweden were slightly more often
primiparous.
Fifty-four percent (5,089/9,459; 53.8%) of respon-
dents were pregnant at the time of completion of the
questionnaire with the remainder (46.2%) having deli-
vered their babies within the previous year. The mean
gestational week was 22.4 among pregnant women.
The majority of the new mothers (51.8%) had babies
under 28 weeks of age.
Prevalence of herbal medicine use in pregnancy
The use of herbal medicines in pregnancy was reported
by 2,735 out of the 9,459 responders (28.9%). Australia,
Poland and Russia had the highest reported rates of
herbal medicine users (Figure 2).
In total, 5,023 herbal medicines were reported by 2,735
women (overall average 1.6 herbal medicines each). The
five most frequently used herbal medicines were ginger,
cranberry, valerian, raspberry and chamomile. Table 1
summarizes the top twenty herbal medicines used overall
and by region. These top twenty herbs represented over
70% of the herbs that were used in pregnancy with ginger
and cranberry used by 46.2% of women using herbals.
Overall, there were 134 different herbs used. Among the
top twenty herbs, there was some regional variation in the
use of specific herbal medicines. Motherwort, centaury
and lovage were used only by women from Eastern
European countries. Cowberry was only reported by
women from Europe while, Uva ursi was used by women
in Western and Eastern Europe only.
Nine percent of the herbal users indicated that they
had a chronic illness; however, less than one percent of
these women used an herbal medicine to manage their
chronic illness (data not shown).
Additional file 4 summarizes the ten most common
reasons for using herbal medicines and the most fre-
quently used herbs, overall and by region. Common
concerns of pregnancy such as cold/flu, nausea, sleeping
problems, constipation and labor preparation were
among the top reasons for using herbal medicines. There
were similarities in the most commonly used herbs used
for these ailments across regions. In addition, UTIs in
pregnancy were commonly treated with cranberry.
Factors associated with herbal medicine use
Additional file 5 summarizes the overall and regional
maternal factors related to herbal medicine use in preg-
nancy. Region of residence was a significant factor in
herbal medicine use. Compared to women in Western
Europe, women in Australia and Eastern Europe were
Figure 1 Participant flow-chart to achieve final analysis sample.
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twice as likely to use an herbal medicine in pregnancy,
while women from Northern Europe were significantly
less likely to use an herbal medicine. Women using
herbal medicines were characteristically having their first
child, non-smokers, using folic acid and consuming
some alcohol in pregnancy. Also, women who were cur-
rently students and women with an education other than
a high school degree were more likely to use herbal
medicines than other women.
Sources of the recommendation to use herbal medicines
Table 2 summarizes the sources for women’s use of
an herbal medicine, by region (country details in
Additional file 6). In most cases the women used herbal
medicine on their own initiative. Informal sources (fam-
ily & friends, internet, magazines and media) represent
over 30% of sources that women indicated that they
accessed. The second highest source was physicians. In
the Eastern European countries, a physician’s recom-
mendation was the most frequently indicated source.
Discussion
This is the first multinational study of the use of herbal
medicine by women during pregnancy and provides
insight into the use of these products in several coun-
tries, in some, for the first time. Three findings are
specifically important. Firstly, we found that the use of
herbal medicine in pregnancy varied considerably between
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Table 1 The 20 most frequently used herbal medicines in pregnancy, overall and according to region
Overall use REGION
Top 20
herbal
medicines
Total
number
of herb
used (n)
% ± SE Western
Europe
n = 888
% ± SE
Northern
Europe
n = 335
% ± SE
Eastern
Europe
n = 1,213
% ± SE
North
America
n = 142
% ± SE
South
America
n = 62
% ± SE
Australia
n = 95
% ± SE
Total number
of women
n = 2,735
% ± SE
Ginger 643 12.8 ± 0.5 28.5 ± 1.5 39.1 ± 2.7 12.2 ± 0.9 40.8 ± 4.1 4.8 ± 2.7 52.6 ± 5.1 23.5 ± 0.8
Cranberry 622 12.4 ± 0.5 10.6 ± 1.0 22.4 ± 2.3 35.7 ± 1.4 6.3 ± 2.0 * 10.5 ± 3.1 22.7 ± 0.8
Valerian 391 7.8 ± 0.5 6.9 ± 0.9 * 26.4 ± 1.3 2.8 ± 1.4 * - 14.3 ± 0.7
Raspberry 301 6.0 ± 0.4 14.8 ± 1.2 11.0 ± 1.7 7.4 ± 0.8 17.6 ± 3.2 - 18.9 ± 4.0 11.0 ± 0.6
Chamomile 194 3.9 ± 0.3 4.2 ± 0.7 1.2 ± 0.6 10.5 ± 0.9 5.6 ± 1.9 27.4 ± 5.7 * 7.1 ± 0.5
Peppermint 188 3.7 ± 0.3 6.5 ± 0.8 2.1 ± 0.8 8.1 ± 0.9 8.5 ± 2.3 12.9 ± 4.3 5.3 ± 2.3 6.9 ± 0.5
Dog rose 149 3.0 ± 0.2 * * 11.8 ± 0.9 * * - 5.4 ± 0.4
Cowberry 142 2.8 ± 0.2 * * 11.5 ± 0.9 - - - 5.2 ± 0.4
Psyllium 132 2.6 ± 0.2 6.1 ± 0.8 1.8 ± 0.7 1.4 ± 0.3 19.7 ± 3.3 12.9 ± 4.3 20.0 ± 4.1 4.8 ± 0.4
Rosemary 98 2.0 ± 0.2 * - 7.7 ± 0.8 - - * 3.6 ± 0.4
Centaury 94 1.9 ± 0.2 - - 7.7 ± 0.8 - - - 3.4 ± 0.3
Lovage 94 1.9 ± 0.2 - - 7.7 ± 0.8 - - - 3.4 ± 0.3
Lemon 93 1.9 ± 0.2 3.8 ± 0.6 * 4.0 ± 0.6 * 6.5 ± 3.1 3.2 ± 1.8 3.4 ± 0.3
Echinacea 92 1.8 ± 0.2 5.0 ± 0.7 4.8 ±1.2 1.5 ± 0.3 6.3 ± 2.0 * 3.2 ± 1.8 3.4 ± 0.3
Lemon Balm 84 1.7 ± 0.2 2.4 ± 0.5 * 4.9 ± 0.6 * * - 3.1 ± 0.3
Motherwort 79 1.6 ± 0.2 - - 6.5 ± 0.7 - - - 2.9 ± 0.3
Garlic 78 1.6 ± 0.2 * * 5.6 ± 0.7 2.8 ± 1.4 - * 2.9 ± 0.3
Fiber crops 66 1.3 ± 0.2 3.6 ± 0.6 * 0.5 ± 0.2 9.9 ± 2.5 * 8.4 ± 2.8 2.4 ± 0.3
Uva ursi 65 1.3 ± 0.2 0.1 ± 0.1 - 5.3 ± 0.6 - - - 2.4 ± 0.3
Total 3,605 72.0 ± 0.6
Summary of herbal medicine used
Total no. of herbs used 1,261 379 2,904 233 110 136 5,023
No. of multiherb products 98 10 368 8 0 1 485
Average no. of herbs used 1.4 0.6 1.1 1.4 1.4 1.4 1.6
No. of different herbs 90 54 83 42 38 24 134
SE: Standard error. Standard errors were calculated for all percentages; however, where the SE > 50% the point estimate is not reported and an “*” is used.
Table 2 Source of the recommendation to use herbal medicine in pregnancy according to region
Percentage of women indicating each recommendation source
Total
responses
Own
initiative
Physician Family &
friends
Internet Midwife,
nurse
Pharmacy
personnel
Magazine
or media
Herbal
shop
Other**
N % ± SE % ± SE % ± SE % ± SE % ± SE % ± SE % ± SE % ± SE % ± SE
Total 3,961 28.6 ± 0.7 21.6 ± 0.7 16.8 ± 0.6 11.3 ± 0.5 7.8 ± 0.4 6.1 ± 0.4 3.3 ± 0.3 3.0 ± 0.3 1.5 ± 0.2
Western Europe 1,315 27.6 ± 1.2 14.7 ± 1.0 18.6 ± 1.1 11.3 ± 0.9 10.2 ± 0.8 7.7 ± 0.7 4.0 ± 0.5 4.0 ± 0.5 2.1 ± 0.4
Northern Europe 548 31.9 ± 2.0 8.6 ± 1.2 19.2 ± 1.7 15.7 ± 1.6 9.1 ± 1.2 5.3 ± 1.0 3.6 ± 0.8 5.7 ± 1.0 0.9 ± 0.4
Eastern Europe 657 28.0 ± 1.8 34.5 ± 1.9 13.3 ±1.3 10.3 ± 1.2 4.9 ± 0.8 5.6 ± 0.9 2.6 ± 0.6 0.8 ± 0.3 *
North America 209 31.6 ± 3.2 8.6 ± 1.9 18.2 ± 2.7 11.5 ± 2.2 13.9 ± 2.4 2.4 ± 1.1 3.3 ± 1.2 3.8 ± 1.3 *
South America 71 22.5 ± 5.0 12.7 ± 4.0 36.6 ± 5.7 8.5 ± 3.3 * * 5.6 ± 2.7 9.9 ± 3.5 -
Australia 161 29.8 ± 3.6 9.9 ± 2.4 21.1 ± 3.2 9.3 ± 2.3 9.3 ± 2.3 8.1 ± 2.2 * 5.6 ± 1.8 *
SE: Standard error. Standard errors were calculated for all percentages; however, where the SE > 50% the point estimate is not reported and an “*” is used.
Note: Women were permitted to indicate more than one source for the recommendation to take an herbal medicine. **Includes sources such as prenatal yoga
class or CAM practitioner.
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countries, but that many of the same herbs are used.
Secondly, there were no specific features that cha-
racterised the woman who used herbal medicines in
pregnancy across all countries. Thirdly, in most countries
women relied on informal information sources in their
decision to use an herbal medicine in pregnancy.
The use of herbal medicines, overall, was 28.9%, and
ranged from a low of 4.3% in Sweden to 69% in Russia. This
range is consistent with results in other studies
[9,10,13,19-23]. The previously reported rate of herbal use
in Finland was 3.6%; 1/3 of what we find in our study. We
found lower prevalence rates of herbal medicine use in
Norway, the UK and Italy than previously reported
[9,10,14], but higher rates in Finland and Sweden [15,24].
In Australia, previous studies have a reported prevalence of
the use of herbal medicine of between 11% to 56%, which
is consistent with our results [25-27]. This variability
may reflect differences in data collection or differences
in time trends. The broad availability of the study ques-
tionnaire might, in fact, promote a more representative
study population rather than reflecting just an antenatal
clinic or specific geographical area. The highest preva-
lence rate of the use of herbal medicines in pregnancy
in Russia, coupled with the 38% of Russian women indi-
cating that the recommendation to use an herbal medi-
cine came from a physician could, in part, be due to the
acceptance of the use of herbal medicines by Russian
physicians. A 2008 survey of physicians in Russia found
that 76% reported the use of phytotherapy and 71% of
herbal medicines in their practice [28]. This country
also was found to have the lowest allopathic medication
use in the survey (Lupattelli A et al: Medication use in
pregnancy: a multinational perspective. 2013 (submitted)).
The top herbal medicines used have been previously
reported to include ginger, cranberry, raspberry,
chamomile, valerian, and echinacea. This is consistent
with the present survey as well. The use of these herbals
was primarily for ailments related to pregnancy; nausea,
UTIs and preparation for labor, rather than to assist with
chronic diseases. Ginger was not only used for nausea
but for cold and flu’s, perhaps due to its diaphoretic
properties [29], health promotion and gastrointestinal
disorders. A literature review the effect of ginger on nau-
sea and vomiting in pregnancy found that ginger maybe
helpful; however, the study results were inconsistent
[30]. The results of a large cohort study with 1,020 ex-
posed pregnancies demonstrated that there was no in-
crease in congenital malformations or poor pregnancy
outcomes after the use of ginger during pregnancy [31].
Cranberry was used for multiple purposes as well; cold
and flu’s, UTIs, health promotion and water retention.
Cranberry’s effectiveness in UTI prophylaxis and UTI
treatment has not been demonstrated [32]. Taking into
account the fact that untreated UTIs can increase the
risk of pregnancy complications, pyelonephritis, impact-
ing fetal growth and preterm delivery [33], the high use
of herbals for UTI in our study is of concern. Health
care professionals should inform pregnant women to use
antibiotics and not herbals to treat UTI in pregnancy.
Raspberry was used for colds and flu’s and health promo-
tion, where its properties would likely provide little benefit,
in addition to the usually associated indication as a uterine
tonic in preparation for labor [34]. A recent literature re-
view concluded that there was lack of evidence for safety
and efficacy in promoting effective labor and questioned its
use in pregnancy in light of the weak evidence that cur-
rently exists [35].
Many sources have suggested that women who use CAM
medicine are characterized as being between the ages of
31-40 years, having higher education and income levels and
used CAM in a previous pregnancy [7,13]. Overall, the
study participants who used herbal medicines were having
their first child, more often students and less likely to work
as healthcare providers, with an educational level other
than high school, non-smokers, using both folic acid and al-
cohol during pregnancy. Several of the factors associated
with herbal medicine users are different from previously re-
ported studies in terms of age and education [13]. However,
Forster et al. did find in their study that herbal medicine
users were more likely to be nulliparous [27]. These differ-
ences from previous studies may simply reflect a more rep-
resentative user group that we were able to reach via the
use of the internet rather than being limited to a specific
antenatal clinic or geographical area. Overall, maternal age
was not a significant determinant of herbal use during
pregnancy apart from Western and Eastern Europe. In the
former region use of herbal remedies was less prevalent
among women younger than 20 years of age than the 21-
30 year counterpart, whereas in the latter it was less preva-
lent among women of 31-40 years of age and more com-
mon among younger women (less than 20 years). Across
the regions, there were also differences in the characteris-
tics of herbal users with respect to parity and employment
status. In fact, while parity and employment status were not
significant determinants of herbal use during pregnancy in
either North or South America or Australia, they were so
in both Western and Eastern Europe. One consistent char-
acteristic across Europe and North America, which has not
been reported previously, is that herbal users were more
likely to continue to consume alcohol once they were aware
they were pregnant. This finding might reflect a certain
open or extravert life style where both herbal medicine and
alcohol consumption use is common [36]. Given that
alcohol is a known teratogen and there is no known safe
amount to consume when pregnant, this would to seem to
contradict the objective of using substances that are per-
ceived to be safe that one might associate with the use of
herbal medicines [37].
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Informal information sources, such as one’s own initia-
tive, friends/family, were the primary sources that
women indicated as involved in their decision to use an
herbal medicine in pregnancy. As several authors have
suggested, this may well reflect a woman’s desire to have
a natural approach to pregnancy [7,38], or perhaps these
women feel more active in their health and feel more
comfortable making their own decisions or a desire to
use less conventional medication. This use could repre-
sent a concern, as studies have found that women will
often not communicate the use of herbal medicines to
their health care providers [14].
There are several strengths in this study. The use of an
internet-based survey permitted access by a large number
of women regarding their use of herbal medicine in preg-
nancy and provided insights on its use in regions and coun-
tries that have not previously been reported. A comparison
of the survey population to the participating countries’
birthing populations found that the responding population
were of similar age, parity and smoking habits, but had a
higher education level. This may suggest that herbal medi-
cine users may be overrepresented in this survey since
higher education levels have been associated with herbal
medicine use and higher education was a significant deter-
minant of herbal use in several regions in the survey results.
Similarly, internet users cluster in higher socioeconomic
classes. The regional variations in the age of herbals users,
suggesting that herbal use is higher amongst younger, nul-
liparous women may reflect an emerging trend in some
countries.
There are also several limitations that should be
mentioned. Firstly, as an internet based study, this may
introduce a population selection bias by access to the
internet. Internet penetration rates are high among the
target population in many of the participating countries,
and recent epidemiological studies indicate reasonable
validity of web-based recruitment methods [39-41]. In
Europe, the penetration rates range from about 50% in
Russia and Serbia, to 100% in Iceland [41,42]. In the
USA, Canada and Australia approximately 80-90% of the
population has access to the internet, though lower rates
(about 50%) apply to South America [42-45]. Hence, the
degree to which our findings can be extrapolated to the
target population is based on the representativeness of
the respondents to the general birthing populations in
each country.
Secondly, a conventional response rate could not be cal-
culated because of the utilization of multiple websites in
each participating country. However, of the women who
expressed their willingness to participate or not in the
study, 98.6% took part and completed the online question-
naire. Thirdly, the potential for recall bias cannot be ex-
cluded here since we were reliant upon women to recall
which herbal medicines were taken and, for 1,351 women
(49.3%), the events were up to one year in the past. Also,
the duration of use of the herbal medicine in pregnancy
was not captured in the survey. However, as 75% of the
herbals users used herbal medicines for pregnancy-related
health ailments, we assume that short term use was most
common. There may also be under reporting of some
herbal medicines as herbal names were not specifically
queried in the questionnaire. Further, when a multi-herbal
product was provided as a response, an internet search for
its ingredients was performed. It is possible that the com-
position of named products could vary from country to
country and these differences would not have been cap-
tured. Our results must be interpreted with these strengths
and limitations in mind.
Conclusions
In this multinational study use of herbal medicine in
pregnancy was high. In total, 134 different herbs were
used, most frequently ginger, cranberry, valerian and
raspberry for pregnancy-related health ailments. There
was variability in both the prevalence of the use and
users of herbal medicines in pregnancy across regions.
Many women primarily used informal information
sources in their decision to use an herbal medicine in
pregnancy in most regions; however, in the Eastern
European countries, physicians’ recommendations were
cited most often.
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